You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Xolair

Showing 1 - 25 of 158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Xolair® for Chronic Rhinosinusitis With Nasal Polyps

Recruiting
  • Chronic Rhinosinusitis With Nasal Polyps
  • Xolair
  • Bundang Gu, Gyeonggi Do, Korea, Republic of
    Novartis Investigative Site
Jan 19, 2023

Xolair® in Pediatric Chronic Spontaneous Urticaria in China

Not yet recruiting
  • Chronic Spontaneous Urticaria
  • Xolair
  • (no location specified)
Sep 19, 2023

Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)

Completed
  • Healthy Volunteers
  • CMAB007
  • Xolair
  • Shanghai, China
    Shanghai Xuhui Central Hospital
Jun 8, 2023

Food Allergy Trial (Drug: Chinese Herbal Medication, Drug: Placebo, Drug: Omalizumab)

Completed
  • Food Allergy
  • Drug: Chinese Herbal Medication
  • +2 more
  • (no location specified)
Oct 24, 2023

Chronic Idiopathic Urticaria Trial (Omalizumab Injection, Xolair Prefilled Syringe)

Not yet recruiting
  • Chronic Idiopathic Urticaria
  • Omalizumab Injection
  • Xolair Prefilled Syringe
  • (no location specified)
Mar 7, 2023

Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria

Recruiting
  • Spontaneous Urticaria, Chronic
    • Lille, France
      Hop Claude Huriez Chu Lille
    Jan 25, 2023

    Healthy Trial in Ahmedabad, Mahesana (ADL-018, US-licensed XOLAIR, EU-Approved XOLAIR)

    Recruiting
    • Healthy
    • ADL-018
    • +2 more
    • Ahmedabad, Gujarat, India
    • +1 more
    Sep 29, 2022

    Food Allergy Trial in Odense C (Omalizumab, Placebo)

    Recruiting
    • Food Allergy
    • Odense C, Funen, Denmark
      Odense Research Center for Anaphylaxis, Allergy Center, Odense U
    Sep 20, 2022

    Healthy Volunteers Trial in Grafton, Christchurch (Omalizumab Prefilled Syringe)

    Recruiting
    • Healthy Volunteers
    • Omalizumab Prefilled Syringe
    • Grafton, Auckland, New Zealand
    • +1 more
    Apr 19, 2022

    Xolair in Severe to Most Severe Seasonal Allergic Rhinitis Aged

    Active, not recruiting
    • Allergic Rhinitis
    • Xolair
    • Inazawa, Aichi, Japan
    • +15 more
    Aug 11, 2022

    Idiopathic Angioedema Trial in Madison (Omalizumab, Placebos)

    Completed
    Has Results
    • Idiopathic Angioedema
    • Madison, Wisconsin
      UW Madison
    Oct 21, 2021

    XOLAIR Outcomes in Pediatric Allergic Asthma United States

    Completed
    • Asthma
    • East Hanover, New Jersey
      Novartis Investigational Site
    Dec 15, 2021

    Autism Spectrum Disorder, Atopy Trial in Boston (Omalizumab Injection [Xolair])

    Withdrawn
    • Autism Spectrum Disorder
    • Atopy
    • Omalizumab Injection [Xolair]
    • Boston, Massachusetts
      Beth Israel Deaconess Medical Center
    Aug 11, 2021

    Chronic Urticaria Trial in United States (TEV-45779, XOLAIR® Injection)

    Recruiting
    • Chronic Urticaria
    • TEV-45779
    • XOLAIR® Injection
    • Bakersfield, California
    • +8 more
    Dec 16, 2021

    Asthma Trial in Shanghai (Omalizumab)

    Completed
    • Asthma
    • Shanghai, Shanghai, China
      Shanghai Xuhui Central Hospital
    Oct 8, 2021

    Chronic Spontaneous Urticaria Trial in Warszawa (CT-P39, EU-approved Xolair)

    Recruiting
    • Chronic Spontaneous Urticaria
    • CT-P39
    • EU-approved Xolair
    • Warszawa, Poland
      Klinika Ambroziak ESTEDERM
    Aug 25, 2021

    Allergic Asthma, Uncontrolled Moderate to Severe Trial in Iran, Islamic Republic of (Omalizumab (CinnaGen), Omalizumab

    Completed
    • Allergic Asthma
    • Uncontrolled Moderate to Severe
    • Omalizumab (CinnaGen)
    • Omalizumab (Genentech, Inc., USA and Novartis Pharmaceuticals Corp, Switzerland)
    • Ahvaz, Iran, Islamic Republic of
    • +21 more
    Apr 3, 2023

    Asthma Trial in Hangzhou (JYB1904, Omalizumab, JYB1904 Placebo)

    Active, not recruiting
    • Asthma
    • Hangzhou, Zhejiang, China
      Shulan (Hangzhou) Hospital
    Oct 23, 2022

    Healthy Trial in Mahesana (Omalizumab 150mg)

    Recruiting
    • Healthy
    • Omalizumab 150mg
    • Mahesana, Gujarat, India
      Registered BE centre
    Nov 4, 2022

    Asthma in Children, Atopy, Viral Upper Respiratory Infection Trial in Washington (Omalizumab, Placebo)

    Recruiting
    • Asthma in Children
    • +2 more
    • Washington, District of Columbia
      Children's National Hospital
    Aug 26, 2022

    Food Allergy Trial in Odense C (Omalizumab Injection)

    Active, not recruiting
    • Food Allergy
    • Omalizumab Injection
    • Odense C, Funen, Denmark
      Odense Research Center for Anaphylaxis, Allergy Center
    Sep 20, 2022

    Nasal Polyps Trial in Shiraz (Omalizumab, SNOT22 score)

    Not yet recruiting
    • Nasal Polyps
    • Shiraz, Fars, Iran, Islamic Republic of
      Imam Reza Allergy and Immunology clinic, Shiraz University of Me
    May 31, 2022

    Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)

    Active, not recruiting
    • Covid19
    • Omalizumab
    • Placebo
    • Niagara, Ontario, Canada
    • +2 more
    Nov 14, 2022

    Chronic Spontaneous Urticaria Trial (SYN008, Omalizumab for injection)

    Not yet recruiting
    • Chronic Spontaneous Urticaria
    • SYN008
    • Omalizumab for injection
    • (no location specified)
    Jun 22, 2021

    Peanut Allergy, Food Allergy Trial in United States (Omalizumab, )

    Active, not recruiting
    Has Results
    • Peanut Allergy
    • Food Allergy
    • Stanford, California
    • +3 more
    Jan 11, 2022